BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 2421361)

  • 1. [Lipoxygenase catalyzation of arachidonic acid metabolism and the effect of its inhibition on anaphylactic reactions].
    Grupe R
    Pharmazie; 1986 Jan; 41(1):7-22. PubMed ID: 2421361
    [No Abstract]   [Full Text] [Related]  

  • 2. The effect of arachidonate lipoxygenase substrates and inhibitors on SRS-A release in the guinea-pig lung [proceedings].
    Morris HR; Piper PJ; Taylor GW; Tippins JR
    Br J Pharmacol; 1979 Jul; 66(3):452P. PubMed ID: 118794
    [No Abstract]   [Full Text] [Related]  

  • 3. Mast cells and mast cell mediators in models of airway disease.
    Peters SP; Naclerio RM; Freeland HS; Togias A; Schleimer RP; MacGlashan DW; Kagey-Sobotka A; Fox CC; Adkinson NF; Lichtenstein LM
    Prog Clin Biol Res; 1985; 199():153-61. PubMed ID: 2999818
    [No Abstract]   [Full Text] [Related]  

  • 4. An analysis of the relationship between 5-lipoxygenase product generation and the secretion of preformed mediators from mouse bone marrow-derived mast cells.
    Razin E; Romeo LC; Krilis S; Liu FT; Lewis RA; Corey EJ; Austen KF
    J Immunol; 1984 Aug; 133(2):938-45. PubMed ID: 6330206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mediator release from human basophils and mast cells from lung and intestinal mucosa.
    Fox CC; Kagey-Sobotka A; Schleimer RP; Peters SP; MacGlashan DW; Lichtenstein LM
    Int Arch Allergy Appl Immunol; 1985; 77(1-2):130-6. PubMed ID: 2409011
    [No Abstract]   [Full Text] [Related]  

  • 6. Lipid mediators of the allergic reaction.
    Chilton FH; Lichtenstein LM
    Chem Immunol; 1990; 49():173-205. PubMed ID: 2112394
    [No Abstract]   [Full Text] [Related]  

  • 7. Regulatory mechanism of arachidonic acid metabolism in rat basophilic leukemia (RBL)-2H3 cells.
    Hamasaki Y; Miyazaki S; Tai HH
    Nihon Ketsueki Gakkai Zasshi; 1987 Jul; 50(4):813-8. PubMed ID: 3120452
    [No Abstract]   [Full Text] [Related]  

  • 8. Ultraviolet erythema: causes and consequences.
    Greaves MW
    Curr Probl Dermatol; 1986; 15():18-24. PubMed ID: 3004813
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of a specific inhibitor of the 5-lipoxygenase pathway on mediator release from human basophils and mast cells.
    Warner JA; Lichtenstein LM; MacGlashan DW
    J Pharmacol Exp Ther; 1988 Oct; 247(1):218-22. PubMed ID: 3139865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of arachidonic acid products in asthma.
    Clay TP; Miller P
    Practitioner; 1984 May; 228(1391):510-3. PubMed ID: 6433339
    [No Abstract]   [Full Text] [Related]  

  • 11. Substrate and regulatory functions of eicosapentaenoic and docosahexaenoic acids for the 5-lipoxygenase pathway. Implications for pulmonary responses.
    Lee TH; Drazen JM; Lewis RA; Austen KF
    Prog Biochem Pharmacol; 1985; 20():1-17. PubMed ID: 2581266
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of arachidonic acid metabolism on the release of histamine and SRS (leukotrienes) from guinea-pig lung.
    Chakravarty N
    Agents Actions; 1984 Apr; 14(3-4):429-34. PubMed ID: 6203364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Biochemical, pharmacological and therapeutic aspects of skin metabolism of arachidonic acid].
    Bouclier M; Hensby CN
    Ann Dermatol Venereol; 1986; 113(12):1289-93. PubMed ID: 3105409
    [No Abstract]   [Full Text] [Related]  

  • 14. Secretory functions of the mononuclear phagocyte.
    Scott WA; Pawlowski NA; Cramer EB; Cohn ZA
    Adv Exp Med Biol; 1985; 183():17-25. PubMed ID: 2994405
    [No Abstract]   [Full Text] [Related]  

  • 15. The mechanism of enhancement by fatty acid hydroperoxides of anaphylactic mediator release.
    Adcock JJ; Garland LG; Moncada S; Salmon JA
    Prostaglandins; 1978 Aug; 16(2):179-87. PubMed ID: 81495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Chemical mediators].
    Okiji T; Murota S
    Tanpakushitsu Kakusan Koso; 1991 Feb; 36(2):171-84. PubMed ID: 1901997
    [No Abstract]   [Full Text] [Related]  

  • 17. Disassociation of the release of histamine and arachidonic acid metabolites from osmotically activated basophils and human lung mast cells.
    Eggleston PA; Kagey-Sobotka A; Proud D; Adkinson NF; Lichtenstein LM
    Am Rev Respir Dis; 1990 Apr; 141(4 Pt 1):960-4. PubMed ID: 1691604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of inhibition of arachidonic acid metabolism on anaphylaxis of guinea pig lung strips.
    Yen SS; Kreutner W
    Agents Actions; 1980 Jun; 10(3):274-8. PubMed ID: 7405754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacologic mediators of bronchoconstriction.
    Parker CW
    Jpn J Pharmacol; 1980; 30(Suppl):10P-13P. PubMed ID: 6113295
    [No Abstract]   [Full Text] [Related]  

  • 20. [Leukotrienes and other products of lipoxygenases. Nature and biological profile].
    Gimeno AL
    Acta Physiol Pharmacol Latinoam; 1985; 35(1):67-92. PubMed ID: 2998154
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.